Viatris, Inc. (NASDAQ: VTRS)

This investigation is for anyone who acquired securities in Viatris, Inc. (NASDAQ: VTRS) from August 8, 2024 through February 26, 2025.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by telling investors that the Company had in place adequate controls over manufacturing when the Company lacked sufficient controls.

On December 23, 2024, Viatris disclosed that “following an inspection by the U.S. FDA” at the Company’s manufacturing facility in Indore “the Agency has issued a Warning Letter, and an Import Alert related to this facility” which “affects 11 actively distributed products that will no longer be accepted into the U.S. until the Warning Letter is lifted.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume. Then, on February 27, 2025, Viatris released its fourth quarter and full year 2025 financial results, reporting, among other things, financial guidance metrics for fiscal year 2025 with “anticipated negative impact from the Indore facility of ~$500 million to total revenues and ~$385 million to adjusted EBITDA.” On this news, the price of the Company’s stock again dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Viatris, Inc. (NASDAQ: VTRS) from August 8, 2024 through February 26, 2025 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.